Paclisanz
Brand Name: Paclisanz
Generic Name: Paclitaxel
Active
Registration Number
DRP-9326
Dosage Form
Solution For I.V. Infusion
Issuance Date
September 1, 2022
Expiry Date
April 22, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength6mg/mL
PackagingUSP Type I Clear and Colorless Glass Vial x 5 mL,
16.7 mL and 43.4 mL (Net Content) [Box of 1's]
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic (Taxane)
A
Application
Automatic Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
PaclitaxelActive
Monograph: Paclitaxel